Publikationen von Sebastian Theurich

Wunderlich, C. M.; Ackermann, J. P.; Ostermann, A. L.; Adams-Quack, P.; Vogt, M. C.; Tran, M.-L.; Nikolajev, A.; Waisman, A.; Garbers, C.; Theurich, S. et al.; Mauer, J.; Hövelmeyer, N.; Wunderlich, F. T.: Obesity exacerbates colitis-associated cancer via IL-6-regulated macrophage polarisation and CCL-20/CCR-6-mediated lymphocyte recruitment. Nature Communications 9 (1), 1646 (2018)

Chakupurakal, G.; Garcia-Marquez, M. A.; Shimabukuro-Vornhagen, A.; Kluth, S.; Schlosser, H.; Theurich, S.; Scheid, C.; Hallek, M.; Holtick, U.; von Bergwelt-Baildon, M.: Regulatory B10 cells display an altered homoeostasis in acute graft-versus-host disease. European Journal of Haematology 98 (2), S. 128 - 133 (2017)

Lechner, A.; Schlößer, H.; Rothschild, S. I.; Thelen, M.; Reuter, S.; Zentis, P.; Shimabukuro-Vornhagen, A.; Theurich, S.; Wennhold, K.; Garcia-Marquez, M. et al.; Tharun, L.; Quaas, A.; Schauss, A.; Isensee, J.; Hucho, T.; Huebbers, C.; von Bergwelt-Baildon, M.; Beutner, D.: Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma. Oncotarget 8 (27), S. 44418 - 44433 (2017)

Theurich, S.; Tsaousidou, E.; Hanssen, R.; Lempradl, A. M.; Mauer, J.; Timper, K.; Schilbach, K.; Folz-Donahue, K.; Heilinger, C.; Sexl, V. et al.; Pospisilik, J. A.; Wunderlich, F. T.; Brüning, J. C.: IL-6/Stat3-dependent induction of a distinct, obesity-associated NK cell subpopulation deteriorates energy and glucose homeostasis. Cell Metabolism 26 (1), S. 171 - 184 (2017)

Wennhold, K.; Weber, T. M.; Klein-Gonzalez, N.; Thelen, M.; Garcia-Marquez, M. A.; Chakupurakal, G.; Fiedler, A.; Schlößer, H.; Fischer, R.; Theurich, S. et al.; Shimabukuro-Vornhagen, A.; von Bergwelt-Baildon, M.: CD40-activated B cells induce anti-tumor immunity in vivo. Oncotarget 8 (17), S. 27740 - 27253 (2017)

Xu, E.; Pereira, M. M.; Karakasilioti, I.; Theurich, S.; Al-Maari, M.; Rappl, G.; Waisman, A.; Wunderlich, F. T.; Brüning, J. C.: Temporal and tissue-specific requirements for T-lymphocyte IL-6 signalling in obesity-associated inflammation and insulin resistance. Nature Communications 8, 14803 (2017)

Becker, H. J.; Kondo, E.; Shimabukuro-Vornhagen, A.; Theurich, S.; von Bergwelt-Baildon, M. S.: Processing and MHC class II presentation of exogenous soluble antigen involving a proteasome-dependent cytosolic pathway in CD40-activated B cells. European Journal of Haematology 97 (2), S. 166 - 174 (2016)

Chakupurakal, G.; Garcia-Marquez, M. A.; Shimabukuro-Vornhagen, A.; Theurich, S.; Holtick, S.; Hallek, M.; Scheid, C.; von Bergwelt-Baildon, M.: Immunological effects in patients with steroid-refractory graft-versus-host disease following treatment with basiliximab, a CD25 monoclonal antibody. European Journal of Haematology 97 (2), S. 121 - 127 (2016)

Jais, A.; Solas, M.; Backes, H.; Chaurasia, B.; Kleinridders, A.; Theurich, S.; Mauer, J.; Steculorum, S. M.; Hampel, B.; Goldau, J. et al.; Alber, J.; Förster, C. Y.; Eming, S. A.; Schwaninger, M.; Ferrara, N.; Karsenty, G.; Brüning, J. C.: Myeloid-cell-derived VEGF maintains brain glucose uptake and limits cognitive impairment in obesity. Cell 165 (4), S. 882 - 895 (2016)

Schlößer, H. A.; Drebber, U.; Kloth, M.; Thelen, M.; Rothschild, S. I.; Haase, S.; Garcia-Marquez, M. A.; Wennhold, K.; Berlth, F.; Urbanski, A. et al.; Alakus, H.; Schauss, A.; Shimabukuro-Vornhagen, A.; Theurich, S.; Warnecke-Ebertz, U.; Stippel, D. L.; Zippelius, A.; Büttner, R.; Hallek, M.; Hölscher, A. H.; Zander, T.; Mönig, S. P.; von Bergwelt-Baildon, M.: Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinoma. Oncoimmunolgy 5 (5), e1100789 (2016)

Theurich, S.; Rothschild, S. I.; Hoffmann, M.; Fabri, M.; Sommer, A.; Garcia-Marquez, M. A.; Thelen, M.; Schill, C.; Merki, R.; Schmid, T. et al.; Koeberle, D.; Zippelius, A.; Baues, C.; Mauch, C.; Tigges, C.; Kreuter, A.; Borggrefe, J.; von Bergwelt-Baildon, M.; Schlaak, M.: Local tumor treatment in combination with systemic ipilimumab immunotherapy prolongs overall survival in patients with advanced malignant melanoma. Cancer Immunology Research 4 (9), S. 744 - 754 (2016)

Wensveen, F. M.; Jelencic, V.; Valentic, S.; Sestan, M.; Wensveen, T. T.; Theurich, S.; Glasner, A.; Mendrila, D.; Stimac, D.; Wunderlich, F. T. et al.; Brüning, J. C.; Mandelboim, O.; Polic, B.: NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nature Immunology 16 (4), S. 376 - 385 (2015)

Garcia-Marquez, M. A.; Shimabukuro-Vornhagen, A.; Theurich, S.; Kochanek, M.; Weber, T.; Wennhold, K.; Dauben, A.; Dzionek, A.; Reinhard, C.; von Bergwelt-Baildon, M.: A multimerized form of recombinant human CD40 ligand supports long-term activation and proliferation of B cells. Cytotherapy 16 (11), S. 1537 - 1544 (2014)

Mauer, J.; Chaurasia, B.; Goldau, J.; Vogt, M. C.; Ruud, J.; Nguyen, K. D.; Theurich, S.; Hausen, A. C.; Schmitz, J.; Brönneke, H. S. et al.; Estevez, E.; Allen, T. L.; Mesaros, A.; Partridge, L.; Febbraio, M. A.; Chawla, A.; Wunderlich, F. T.; Brüning, J. C.: Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin. Nature Immunology 15 (5), S. 423 - 430 (2014)